In a report released today, Graig Suvannavejh from Mizuho Securities maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research Report), with a price target of $30.00. See what stocks ...

Scotiabank analyst Greg Harrison maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research Report) today and set a price target of $30.00. The company’s shares closed last Friday at ...

Apellis Pharmaceuticals Inc (NASDAQ:APLS) is set to release its Q4 2024 earnings on Feb 28, 2025. The consensus estimate for Q4 2024 revenue is $198.35 million, and the earnings are expected to ...

In this article, we are going to take a look at where Apellis Pharmaceuticals (NASDAQ:APLS) stands against other top insider stock buys and sells in January. Ever heard of the “January effect?” ...

Pat McAfee saw the “terrible things that were said about me” after he blasted Canada due to fans in Toronto booing “The Star-Spangled Banner” at a WWE’s Elimination Chamber on Saturday ...

Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Apellis Pharmaceuticals fourth quarter and full-year 2024 earnings conference call. [Operator Instructions] Please ...

Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its target price cut by analysts at Royal Bank of Canada from $26.00 to $25.00 in a report issued on Monday,Benzinga reports.

PHOENIX (AZFamily) — Arizona State University’s head football coach will be the official race starter for this year’s Pat’s Run, the foundation announced Thursday. “Coach Dillingham is a ...

Pat Butcher’s earrings were as big an EastEnders character as her during her 26 years on Albert Square. But now actress Pam St Clement has revealed a huge secret about her character’s ...

Several other research analysts also recently weighed in on APLS. Citigroup dropped their price target on Apellis Pharmaceuticals from $63.00 to $51.00 and set a “buy” rating for the company ...